Dragonfly Therapeutics, Inc., a clinical stage biotechnology company developing novel immunotherapies, announced the April 13th publication of preclinical data in Cell Press's Med supporting DF6002...
NSF, a leading global public health and safety organization, today named Jose Luis Borrero its Chief Financial Officer. Borrero brings strong financial and operational...
Covaris, LLC, a leader in pre-analytical sample preparation technologies, proudly unveils a comprehensive, fully automatable deparaffinization and total nucleic acid extraction workflow for formalin-fixed...
The U.S. Food and Drug Administration approved Omisirge, a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a...
Gamida Cell Ltd, a cell therapy pioneer working to turn cells into powerful therapeutics, announced that the U.S. Food and Drug Administration (FDA) has...
